Table 2 Weight and corresponding weight loss of Lf/(BSA-TA)4 microcapsules upon their treatment with simulated gastric (SGF) and intestine (SIF) fluids.

From: Formulation for Oral Delivery of Lactoferrin Based on Bovine Serum Albumin and Tannic Acid Multilayer Microcapsules

 

Weight, mg

Weight loss, %

CaCO3/(BSA-TA)4

317.2 ± 6

NA

(BSA-TA)4

15 ± 2

NA

Lf/(BSA-TA)4

32.1 ± 3

0

SGF, 60 min

30.6 ± 1

5 ± 3

SIF, 3 min

9 ± 2

72 ± 6

SIF, 10 min

1.10 ± 0.08

96.6 ± 0.25

SIF, 60 min

0.9 ± 0.6

97.2 ± 2